16:05 EDT Longeveron (LGVN) files to sell 3.85M shares of Class A common stock
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGVN:
- Longeveron licenses patent for stem cell technology from University of Miami
- Longeveron Gains FDA Approval for Laromestrocel Trial
- Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
- Longeveron announces FDA approval of IND application for laromestrocel study
- Longeveron appoints Powell as Chief Business Officer